Abstract Background Patients with degenerated surgical bioprosthetic valves may be at high risk for further surgery because of age, comorbidities and the difficulties of repeat procedures. Percutaneous valve-in-valve implantation offers…
Abstract Background Novel bare metal stents with improved stent design may become a viable alternative to drug-eluting stents in certain patient groups, particularly, when long-term dual antiplatelet therapy should be…
Abstract Background/Purpose Family history of coronary artery disease (CAD) is a well-established risk factor of future cardiovascular events. The authors sought to examine the relationship between family history of CAD…
Abstract Objectives This study aims to establish if transfer distance impacts the outcome of ST-elevation myocardial infarction (STEMI) patients transferred to a percutaneous coronary intervention (PCI). Background Regional emergency care…
On October 14, 2014, the US Food and Drug Administration (FDA) granted approval for the Lutonix® Drug Coated Balloon (DCB) Catheter (CR Bard, Inc.) for percutaneous transluminal angioplasty (PTA), after…
